The expression of DCC protein in female breast cancer

Breast Cancer Research and Treatment

Volumn 80, Issue 2, 2003, Pages 215-220

  Koren, Rumelia ^a,b   Dekel, Yoram ^a,b   Sherman, Evgeny ^a,b   Weissman, Yona ^a,b   Dreznik, Zeev ^a,b   Klein, Baruch ^a,b   Gal, Rivka ^a,b  

^a HASHARON HOSPITAL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Breast cancer; Chromosome 18q21; DCC; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DELETED IN COLORECTAL CANCER PROTEIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHROMOSOME 18Q; DCC GENE; FEMALE; GENE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PARTIAL MASTECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECEPTORS, CELL SURFACE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR SUPPRESSOR PROTEINS;

EID: 0038675071     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024581508474     Document Type: Article

References (22)

1. Garfinkel L, Boring CC, Heath Jr CW: Changing trends. An overview of breast cancer incidence and mortality. Cancer 74: 222-227, 1994
2. Higginson J, Muir CS, Muñoz N: Cambridge Monographs on Cancer Research, Human Cancer: Epidemiology and Environmental Causes. Cambridge University Press, Cambridge, UK, 1992, pp 377-387
3. Sloane JP: Biopsy Pathology of the Breast. 2nd edn, Arnold, London, UK, 2001, pp 41-42
4. Biggs PJ, Warren W, Venitt S, Stratton MR: Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unravelling the aetiology of cancer. Mutagenesis 8: 275-283, 1993
5. Olivier M, Hainaut P: TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis. Semin Cancer Biol 11: 353-360, 2001
6. Hoops TC, Traber PG: Molecular pathogenesis of colorectal cancer. Haematol Oncol Clin N Am 11: 609-633, 1997
7. Fearon ER, Ekstrand BC, Hu G, Pierceall WE, Reale MA, Binger SH: Studies of the deleted in colorectal cancer gene in normal and neoplastic tissues. Cold Spring Harbour Symposium. Quant Biol 59: 637-643, 1994
8. Fearon ER: DCC: is there a connection between tumorigenesis and cell guidance molecules? Biochim Biophys Acta 1288: 17-23, 1996
9. Enomoto T, Fujita M, Cheng C, Nakashima R, Ozaki M, Inoue M, Nomura T: Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Br J Cancer 71: 462-467, 1995
10. Porfiri E, Secker-Walker LM, Hoffbrand AV, Hancock JF: DCC tumor suppressor gene is inactivated in haematologic malignancies showing monosomy 18. Blood 81: 2696-2701, 1993
11. Jen J, Kim H: Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331: 213-221, 1994
12. Saito M, Yamaguchi A, Goi T, Tsuchiyama T, Nakagawara G, Urano T, Shiku H, Furukawa K: Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis. Oncology 56: 134-141, 1999
13. Reymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F: DCC protein as a predictor of distant metastases after curative surgery for rectal cancer. Dis Colon Rectum 41: 755-760, 1998
14. Jessup JM, Loda M: Prognostic markers in rectal carcinoma. Semin Surg Oncol 15: 131-140, 1998
15. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377, 1957
16. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991
17. Sobin LH, Wittekind Ch: TNM Classification of Malignant Tumors. 5th edn, Wiley/Liss, New York, 1997, pp 66-73
18. Hayes DF, Bast RC, Desch CE, Fritsche Jr H, Kemeny NE, Jessup JM, Locker GY, Macdonald JS, Mennel RG, Norton L, Ravdin P, Taube S, Winn RJ: Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 88: 1456-1466, 1996
19. Ho KYK, Kalle WHJ: Reduced expression of APC and DCC gene protein in breast carcinoma. Histopathology 35: 249-256, 1999
20. Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ: Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene 6: 311-315, 1991
21. Thompson IS, Morris RG, Wallace M, Wyllie AH, Steel CM, Carter DC: Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 68: 64-68, 1993
22. Hsu YH, Shaw CK: The DCC protein expression in breast carcinoma. Kaohsiung J Med Sci 16: 233-240, 2000